ResearcherUniversity Hospitals Bristol and Weston NHS Foundation TrustActive in the last 2 years

Emily Britton

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9001-1739; OpenAlex author ID A5040290830. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

A systematic review of clinical outcome reporting for curative surgical treatment of patients with pancreatic adenocarcinoma. Co-author DOI 10.1016/j.hpb.2025.02.008 ↗
Definition and management of intra-abdominal metachronous oligometastatic pancreatic cancer: a systematic review. First author DOI 10.1093/bjs/znad338 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jonathan R.E. Rees · 1 shared paper, 2025 · strength 0.28
- Paper A systematic review of clinical outcome reporting for curative surgical treatment of patients with pancreatic adenocarc… DOI 10.1016/j.hpb.2025.02.008 ↗
Katie Boag · 1 shared paper, 2024 · strength 0.24
- Paper Definition and management of intra-abdominal metachronous oligometastatic pancreatic cancer: a systematic review. DOI 10.1093/bjs/znad338 ↗
Samir Pathak · 1 shared paper, 2024 · strength 0.24
- Paper Definition and management of intra-abdominal metachronous oligometastatic pancreatic cancer: a systematic review. DOI 10.1093/bjs/znad338 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.